With respect to complex cross-border projects we provide our expertise to German companies in France, French companies in Germany as well as to German-French companies worldwide.
Latest news & insights
Life Sciences Legal Lens Vol. 2
A European Perspective #2
9 Insights
France renews its simplified anti-gift conventions – what life sciences companies operating in France need to know
France enforces one of Europe's strictest anti-gift regimes, broadly prohibiting any benefit to healthcare professionals, in particular. Within this framework, simplified conventions offer a practical derogation — allowing companies to bundle hospitality declarations into a single filing. These conventions have just been renewed for another two years, with notable developments: COMIDENT (dental sector) joins as a signatory and a new two-month deadline applies for participant list submissions for certain types of convention.
by Annabelle Lebaudy and Marine Boullenger
5 of 9 Insights
Update: AI-Enabled Medical Devices and IVDs Confirmed as “High-Risk”
Digital Omnibus Update. More time (up to August 2028) yet confirming that AI-enabled medical devices and IVDs stay subject to the AI Act.
4 of 9 Insights
Medical Cannabis Platforms Breach Advertising Ban
Case law – German Federal Court of Justice (Bundesgerichtshof) – Online platforms brokering medical cannabis treatments breach the prohibition of public advertising under the German Healthcare Advertising Act
by Irina Rebin
7 of 9 Insights
Tightening of the “BIS Rules” for Connected Vehicle Technologies in the U.S. – Challenge for global Automotive Companies with China-Nexus
Restrictions on “Chinese” vehicle technologies in the U.S. – What’s it about?
by Thomas Kahl and Dajin Lie